| Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma W Zhang, N Nandakumar, Y Shi, M Manzano, A Smith, G Graham, ... Science signaling 7 (324), ra42-ra42, 2014 | 409 | 2014 |
| Circulating biomarkers to monitor cancer progression and treatment S Rapisuwon, EE Vietsch, A Wellstein Computational and structural biotechnology journal 14, 211-222, 2016 | 169 | 2016 |
| Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy OC Rodriguez, S Choudhury, V Kolukula, EE Vietsch, J Catania, A Preet, ... Cell cycle 11 (23), 4436-4446, 2012 | 146 | 2012 |
| Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice I Peran, S Dakshanamurthy, MD McCoy, A Mavropoulos, B Allo, ... Gastroenterology 160 (4), 1359-1372. e13, 2021 | 70 | 2021 |
| Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer EE Vietsch, GT Graham, JN McCutcheon, A Javaid, G Giaccone, ... Cancer genetics 218, 39-50, 2017 | 53 | 2017 |
| Organoids derived from neoadjuvant FOLFIRINOX patients recapitulate therapy resistance in pancreatic ductal adenocarcinoma EA Farshadi, J Chang, B Sampadi, M Doukas, F Van't Land, ... Clinical Cancer Research 27 (23), 6602-6612, 2021 | 44 | 2021 |
| Circulating biomarkers for prediction of objective response to chemotherapy in pancreatic cancer patients F van der Sijde, EE Vietsch, DAM Mustafa, MG Besselink, ... Cancers 11 (1), 93, 2019 | 36 | 2019 |
| Circulating DNA and micro-RNA in patients with pancreatic cancer EE Vietsch, CHJ van Eijck, A Wellstein Pancreatic disorders & therapy 5 (2), 156, 2015 | 36 | 2015 |
| Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib N Shivapurkar, EE Vietsch, E Carney, C Isaacs, A Wellstein Clinical and translational medicine 6, 1-10, 2017 | 25 | 2017 |
| Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity YN Lin, MO Schmidt, GM Sharif, EE Vietsch, AJ Kiliti, ME Barefoot, ... Oncoimmunology 11 (1), 2027136, 2022 | 19 | 2022 |
| Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients F van der Sijde, WA Dik, DAM Mustafa, EE Vietsch, MG Besselink, ... Frontiers in Immunology 13, 898498, 2022 | 17 | 2022 |
| Serum miR-373-3p and miR-194-5p are associated with early tumor progression during FOLFIRINOX treatment in pancreatic cancer patients: a prospective multicenter study F van der Sijde, MYV Homs, ML van Bekkum, TPP van den Bosch, ... International Journal Of Molecular Sciences 22 (20), 10902, 2021 | 15 | 2021 |
| Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX F van der Sijde, Z Azmani, MG Besselink, BA Bonsing, JWB de Groot, ... Therapeutic Advances in Medical Oncology 13, 17588359211033704, 2021 | 14 | 2021 |
| Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer F van der Sijde, EE Vietsch, DAM Mustafa, Y Li, CHJ van Eijck Clinica Chimica Acta 505, 183-189, 2020 | 13 | 2020 |
| Endogenous gastrin collaborates with mutant KRAS in pancreatic carcinogenesis S Nadella, J Burks, M Huber, J Wang, H Cao, B Kallakury, RD Tucker, ... Pancreas 48 (7), 894-903, 2019 | 10 | 2019 |
| Circulating immunological biomarkers: prognosis of pancreatic cancer patients reflected by the immune system F van der Sijde, DAM Mustafa, EE Vietsch, PD Katsikis, CHJ van Eijck Pancreas 50 (7), 933-941, 2021 | 9 | 2021 |
| Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer EE Vietsch, GT Graham, JN McCutcheon, A Javaid, G Giaccone, ... Cancer Genetics 228, 131-142, 2018 | 6 | 2018 |
| Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection V Eveline E, I Peran, M Suker, TPP van den Bosch, F van der Sijde, ... Applied Sciences 9 (22), 4784, 2019 | 4 | 2019 |
| FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction CWF van Eijck, G Strijk, EE Vietsch, F van der Sijde, M Verheij, ... European Journal of Cancer 196, 113440, 2024 | 3 | 2024 |
| Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation SM Roth, EE Vietsch, ME Barefoot, MO Schmidt, MD Park, A Ramesh, ... Gastrointestinal Disorders 3 (3), 100-112, 2021 | 3 | 2021 |
